Medical Innovation Bill ‘Cures 2.0' to See Action This Summer

The biomedical innovation legislation “Cures 2.0" is likely to come up for a vote in the House Energy and Commerce Committee in the coming weeks, the bill’s Republican architect told Bloomberg Government.

Cures 2.0 is the follow-up bill to the 2016 landmark law 21st Century Cures (Pub. L. 114-255) by Reps. Fred Upton (R-Mich.) and Diana DeGette (D-Colo.). It was designed to accelerate medical development and bring new innovations to patients more quickly.

The bipartisan Cures 2.0 would build on the earlier law, in part by addressing the lasting effects of Covid-19 and making it easier for patients ...